148031-34-9
Product Name:
Eptifibatide Acetate
Formula:
C35H49N11O9S2
Synonyms:
Cyclo(S,S)-Mpr(Har)GDWPC-NH2 acetate;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide cyclic (16)-disulfide acetate
Inquiry
COMPUTED DESCRIPTORS
Molecular Weight | 832.0 g/mol |
---|---|
XLogP3 | -2.4 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 10 |
Exact Mass | 831.31561453 g/mol |
Monoisotopic Mass | 831.31561453 g/mol |
Topological Polar Surface Area | 377 Ų |
Heavy Atom Count | 57 |
Formal Charge | 0 |
Complexity | 1520 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 5 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.